Molecular targeted therapy for acute myeloid leukemia / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 8-11, 2019.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-732676
Biblioteca responsável:
WPRO
ABSTRACT
In recent years, genetic alterations have played a crucial role in the diagnosis and prognostic stratification of acute myeloid leukemia (AML) and provided targeted spots for molecular targeted therapy. Due to the limitations of traditional chemotherapy, more and more targeted drugs are going to clinic or undergoing clinical trials. This article introduces several molecular targeted agents reported in the 60th American Society of Hematology (ASH) Annual Meeting.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2019
Tipo de documento:
Artigo